ROCKAWAY, N.J., Sept. 21, 2022 electroCore, Inc. , a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark Office has issued four patents. | September 21, 2022
21.09.2022 - Four patents issued expanding claims related to delivery of nVNS and other therapies using mobile devicesROCKAWAY, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) - electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today . Seite 1
Pain Management to Remain Key Application Area of Electrical Stimulation Devices, Says Fact MR forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Spinal muscular atrophy (SMA) is a rare disease caused by a recessive gene mutation, which affects the patient’s central nervous system, making it difficult for them to move.